Biotechnologists and pharmacists! They are waiting for you in Skolkovo!
Skolkovo will support research in the fields of biomedicine, pharmacology, bioenergy, industrial biotechnologies and bioinformatics.
20.12.2010Skolkovo will support research in the fields of biomedicine, pharmacology, bioenergy, industrial biotechnologies and bioinformatics.
20.12.2010A wide entry into the Russian market of new domestic medicines, even with very high optimism, can be expected no earlier than 2018-2019.
18.11.2010The history of the St. Petersburg company Fractal Bio, which supplies reagents for DNA diagnostics, is an example from a textbook.
15.11.2010Preparations based on SkQ1 – "Skulachev ions" – increase life expectancy and are effective in the prevention and treatment of age-related diseases. The developers are already preparing for the organization of production, to begin with – drops for the treatment of glaucoma and other eye diseases.
02.11.2010Today, the first phase of clinical trials of a DNA vaccine against HIV begins on the basis of the Pavlov St. Petersburg Medical University.
02.11.2010So far, HimRar has submitted one project to the seed fund, a drug for the treatment of alcohol addiction. In August, the firm plans to submit two more projects to the RVC FPI, and 5-10 projects by the end of the year.
27.08.2010The Russian Academy of Medical Sciences believes that the production of its own strategically important drugs instead of Western analogues will not make medicines available to patients, but will only help customers and manufacturers to share public money.
14.07.2010Denis Manturov, Deputy Minister of Industry and Trade of the Russian Federation, spoke about how the Federal Target Program "Pharma 2020" will develop the domestic pharmaceutical market and increase the life expectancy of citizens.
14.07.2010Five years of talking about the need to develop biotechnologies have not led to tangible results. Out of a couple dozen projects that have opened, only a few have been successful, many have died. But hope lives on.
22.06.2010Research in the field of molecular biology allowed Alexey Pogoda to earn 3 million rubles. Now he is bringing test systems to the market to determine hereditary diseases.
21.06.2010A breakthrough is being prepared in the pharmaceutical market. Pharmaceutical companies, in parallel with the production of medicines, are beginning to develop the latest methods and diagnostics for the treatment of patients.
18.06.2010What should the Russian pharmaceutical industry rely on: imported technologies or domestic innovative drugs?
03.06.2010Special attention in the center is supposed to be paid to preclinical studies of nanosubstances, nanomedical preparations and nanovaccines for safety, effectiveness and compliance with technological parameters.
03.06.2010The opportunity to revive the pharmaceutical industry has either already been missed, or it is about to happen. There is no need to invent a new one, because there is not enough strength – it is worth concentrating on revising the old one.
02.06.2010Oleg Medvedev, Professor, Head of the Department of Pharmacology of the Faculty of Fundamental Medicine of Moscow State University: "Pharma 2020" is a planned backlog program.
18.05.2010"Giamatrix", a substitute for living skin based on a polymer of hyaluronic acid, closes a burn or wound and helps healing, as it resolves. A cosmetic version of the bio-skin and an anti-aging peptide complex have already gone on sale.
11.05.2010The traditional model of drug development stops working. Global pharmaceutical companies are looking for a way out in the concept of open innovation. Russian companies also have a chance to fit into this concept.
20.04.2010Maxim Uvarov, CEO of Binnopharm CJSC: "Promising scientists are like rare birds from the Red Book: we have to fight for every valuable specimen.
12.04.2010There are all possibilities to rid the country of "insulin dependence". Russia can fully provide a growing number of diabetics with high-quality and modern domestic insulin.
05.04.2010Genetic testing for warfarin tolerance costs about $250, and a monthly course of treatment costs less than $ 6. But a decrease in the number of hospitalizations due to an overdose of an anticoagulant repeatedly recoups the cost of testing.
19.03.2010You can write to the editor at:
vm@vechnayamolodost.ruThe editors of Eternal Youth are preparing a useful and interesting mailing list. You can get it if you leave your mail.